Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aveo Oncology
Aveo Oncology
Aveo touts new hope for its thrice-failed cancer drug
Fierce Biotech
Fri, 03/6/15 - 11:22 am
Aveo Oncology
tivozanib
Aveo Oncology gets initial warning from Nasdaq that it could be delisted
Bizjournals.com
Tue, 12/30/14 - 11:55 am
Aveo Oncology
NASDAQ
Aveo Oncology to end breast cancer study due to low enrollment
Yahoo/Reuters
Thu, 01/30/14 - 10:07 am
Aveo Oncology
Astellas
tivozanib
breast cancer
clinical trials
The Best- And Worst-Performing Biotech Stocks Of 2013
Forbes
Thu, 01/2/14 - 10:45 am
biotech
Puma Biotechnology
Acadia
Isis Pharmaceuticals
Infinity Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Aveo Oncology
The Worst Biotech CEO of 2013 Is...
TheStreet.com
Tue, 12/17/13 - 08:48 am
biotech
Vical
Ariad Pharma
Aveo Oncology
Dendreon
Amarin
Aveo says lead drug unlikely to succeed in colon cancer study
Yahoo/Reuters
Fri, 12/13/13 - 08:53 am
colon cancer
Aveo Oncology
tivozanib
Karyopharm Therapeutics IPO Looks Promising
Seeking Alpha
Wed, 11/6/13 - 08:19 am
Karyopharm
IPOs
Pfizer
Aveo Oncology
ONYX Pharmaceuticals
Aveo defends kidney cancer drug rejected by the FDA
Boston Globe, MA
Wed, 06/12/13 - 09:15 am
kidney cancer
FDA
Aveo Oncology
tivozanib
FDA rejects Aveo kidney cancer drug, asks for additional trial
Reuters
Mon, 06/10/13 - 11:20 am
FDA
kidney cancer
Aveo Oncology
tivozanib
Aveo's Future Depends on Triple-Negative Breast Cancer
TheStreet.com
Thu, 06/6/13 - 10:35 am
Aveo Oncology
triple-negative breast cancer
tivozanib
Aveo to slash 62 pct jobs; focus on colon, breast cancer drug
Reuters
Wed, 06/5/13 - 12:22 pm
Aveo Oncology
layoffs
Aveo Screwed Up but Its Kidney Cancer Drug Is Real
TheStreet.com
Wed, 05/15/13 - 10:37 am
kidney cancer
Aveo Oncology
tivozanib
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Aveo Gets Bad News On Tivozanib
Seeking Alpha
Thu, 05/2/13 - 03:42 pm
tivozanib
Aveo Oncology
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
FDA
advisory panels
tivozanib
Delcath
Aveo Oncology
kidney cancer
Melblez
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Yahoo/Fly on the Wall
Mon, 10/1/12 - 10:41 am
Aveo Oncology
ficlatuzumab
gefitinib
non-small cell lung cancer
Pages
« first
‹ previous
1
2